HOME >> BIOLOGY >> NEWS
Vietnam last on vaccine list

DRUG company contracts and intellectual property rights are impeding efforts to ensure an outbreak of bird flu in Vietnam does not result in a deadly human pandemic.

All the victims so far got the disease from poultry, but the big fear is that the virus could turn into a form capable of spreading from person to person.

A flu vaccine that might help prevent this will soon become available, but instead of going to Vietnam it will be sent to rich countries to fulfil existing contracts. And researchers who have created vaccines that might save us if the bird flu does start spreading between people are unsure how to proceed without falling foul of patent rights.

Doctors have been warning for years that another flu pandemic as deadly as the 1918 one is inevitable, and many worry it could be about to happen.

After an outbreak of the H5N1 strain of bird flu in poultry, Vietnam has reported 18 suspected human cases, 15 of whom have died. The World Health Organization has so far confirmed that five of the cases were caused by the H5N1 strain.

Unlike previous H5N1 outbreaks, the victims are mostly children. So far there is no sign of the bird virus spreading between people. But if someone is infected by H5N1 and a normal human flu virus at the same time, the viruses could recombine.

This might give rise to a new virus able to spread among people as easily as human flu but far more deadly, partly because it would bear the bird flu's H5 and N1 surface proteins, which human immune systems have not been primed to recognise.

To prevent this, the WHO wants to give the normal flu vaccine to everyone who might come into contact with sick poultry, as has been done in past outbreaks of bird flu.

The Belgian-based company Solvay, a major flu vaccine producer, is supplying the WHO with the vaccine used in the northern hemisphere this winter. But research published last week by the US Centers for Disease Control shows
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
21-Jan-2004


Page: 1 2 3

Related biology news :

1. Lone Vietnamese turtle may be last of its kind
2. Botanists discover new conifer species in Vietnam
3. Northern Vietnam drinking water contains dangerous arsenic levels
4. Combat Has Little Influence On Health Problems In Vietnam Vets
5. Vietnamese Chemist Finds New Use For Old Cashew Shells
6. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
7. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
8. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
9. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
10. Protective gene may enhance vaccine responses
11. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/22/2018)... ... December 21, 2018 , ... ... and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China Managing ... China.” , The discussion was moderated by patent attorney David J. Dykeman ...
(Date:12/19/2018)... (PRWEB) , ... December 19, 2018 , ... InTouchMD’s flagship ... innovative products in healthcare for 2018. , PM360 is featuring the recognition in ... products and services offered to the pharmaceutical and medical device industries. , “This ...
(Date:12/18/2018)... ... December 18, 2018 , ... ... cancers and other serious diseases, today announced the publication of an early feasibility ... treatment of rGBM. , The publication of the study, An Early Feasibility ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today announced ... candidate, code-named "KM-819." KM-819 is an orally active small molecule that is ... Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to ...
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection and desire to improve ... the European Union (EU) on the horizon, Jim Kasic, president and CEO of Boulder ... the EU Medical Device Regulation (MDR), digital health, and big data are just a ...
(Date:12/18/2018)... ... ... Patients with early stages of breast cancer who undergo partial breast proton ... irradiation, a new study suggests. , Patients with early stage breast cancer — stage ... the cancerous tumor because there is a 30 to 40 percent change the disease ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
Breaking Biology Technology:
Cached News: